New Biotech Company Emerges to Tackle Multifunctional Biotherapeutics

A new biotechnology company has emerged with hopes of creating next-generation, antibody-based multifunctional biotherapeutics.

On Thursday, Tentarix Biotherapeutics announced that it earned $50 million in a Series A financing round, which was co-led by Versant Ventures and Samsara BioCapital.